Ozempic, Wegovy, and compounded Semaglutide all contain the same active ingredient, Semaglutide. Ozempic® is primarily prescribed for managing type 2 diabetes by improving blood sugar levels and reducing the risk of major cardiovascular events. Wegovy® is a weekly injection approved by the FDA in 2021 for long-term weight management. Semaglutide, as the active ingredient in both Ozempic® and Wegovy®, has shown the potential to reduce body mass by up to 15%.